Recent Blog Posts

View Post: US FDA speeds up review for velaglucerase alfa to treat Gaucher ...
5 Nov 2009 by pillscribe  
Velaglucerase alfa, an enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease, has been granted priority review by the United States Food and Drug Administration, maker of the drug Shire plc announced. ...
View Blog: DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/

---

View Post: FDA Grants Priority Review for Shire's velaglucerase alfa for Type ...
3 Nov 2009
FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease- FDA Issued Action Date of February 28, 2010 Under the Prescription Drug User Free Act (PDUFA)PR NewswireCAMBRIDGE, Massachusetts, November 4CAMBRIDGE, ...
View Blog: Pharmaceutical Jobs - Research and Development... - http://www.pharmiweb.com/

---

View Post: FDA Grants Priority Review for Shire's velaglucerase alfa for Type ...
3 Nov 2009 by Prne  
CAMBRIDGE, Massachusetts - - FDA Issued Action Date of February 28, 2010 Under the Prescription Drug User Free Act (PDUFA) Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the ...
View Blog: PR Hub - http://blog.taragana.com/pr/

---

View Post: FDA Grants Priority Review for Shire's velaglucerase alfa for Type ...
4 Nov 2009
CAMBRIDGE, Massachusetts, November 4/PRNewswire-FirstCall/ -- Shire plc, the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review for the New ...
View Blog: Drugs.com - New Drug Applications - http://www.drugs.com/new-drug-applications.html

---

View Post: First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule ...
20 Oct 2009 by India-News  
ENCORE is a randomized, open-label study for adult patients with Gaucher disease type 1 designed to compare Genz-112638 to Cerezyme® (imiglucerase for injection). Adult patients who have previously received Cerezyme for at least three ...
View Blog: Business & Finance News - http://trak.in/india/

---

View Post: US FDA grants priority review for Shire's velaglucerase alfa for ...
6 Nov 2009 by cjoelprounding  
Shire plc, the global specialty biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for velaglucerase alfa, the company's enzyme ...
View Blog: disease database - http://diseasedatabase.org/

---

View Post: The Parkinson's Disease – Gaucher Disease link
Little Miss Hannah
22 Oct 2009 by Mommy   ...
View Blog: http://littlemisshannah.com/

---